Acadia Healthcare (NASDAQ:ACHC) Stock Passes Above 200 Day Moving Average – Here’s What Happened

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $19.01 and traded as high as $26.65. Acadia Healthcare shares last traded at $26.61, with a volume of 2,039,257 shares trading hands.

Analysts Set New Price Targets

Several equities analysts have recently weighed in on the company. Zacks Research upgraded Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Barclays lifted their price objective on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a report on Tuesday, March 3rd. Royal Bank Of Canada boosted their price objective on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a research report on Thursday, February 26th. Leerink Partners increased their target price on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a report on Thursday, February 26th. Finally, Mizuho cut their price target on shares of Acadia Healthcare from $22.00 to $17.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th. Seven investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $21.46.

Acadia Healthcare Trading Up 0.4%

The company has a market cap of $2.48 billion, a P/E ratio of -2.21, a PEG ratio of 9.08 and a beta of 0.71. The company has a current ratio of 1.55, a quick ratio of 1.55 and a debt-to-equity ratio of 1.27. The business has a 50 day moving average price of $22.32 and a 200-day moving average price of $19.09.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.04. The firm had revenue of $821.46 million for the quarter, compared to analysts’ expectations of $800.10 million. Acadia Healthcare had a negative net margin of 33.29% and a positive return on equity of 6.53%. The business’s revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. Analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in ACHC. Goldman Sachs Group Inc. increased its position in Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new position in Acadia Healthcare during the 4th quarter worth $47,960,000. Wellington Management Group LLP increased its position in Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after buying an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare during the first quarter worth approximately $43,017,000. Finally, Invenomic Capital Management LP increased its holdings in shares of Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after purchasing an additional 1,375,647 shares during the period.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.